Escríbenos a:
Pharmaceutical and drug registration in Peru is managed under DIGEMID requirements and is a fundamental step for international manufacturers seeking to introduce and commercialize pharmaceutical products in the Peruvian market.
At IzzoMed, we provide pharmaceutical regulatory affairs and consulting services in Peru for companies and manufacturers that need to manage pharmaceutical registration in Peru, from initial product assessment and documentation review through dossier preparation and management of the applicable procedure before DIGEMID.
Our work begins by identifying the requirements applicable to the pharmaceutical product and assessing the available documentation. This allows us to establish an appropriate regulatory strategy for each product and project.
We work with local and international manufacturers, including pharmaceutical companies seeking to introduce products into the Peruvian market and requiring regulatory support and local representation.
At IzzoMed, we provide pharmaceutical regulatory affairs and consulting services in Peru for companies and manufacturers that need to manage pharmaceutical registration in Peru, from initial product assessment and documentation review through dossier preparation and management of the applicable procedure before DIGEMID.
Our work begins by identifying the requirements applicable to the pharmaceutical product and assessing the available documentation. This allows us to establish an appropriate regulatory strategy for each product and project.
We work with local and international manufacturers, including pharmaceutical companies seeking to introduce products into the Peruvian market and requiring regulatory support and local representation.
Pharmaceutical Registration in Peru
Each pharmaceutical product and manufacturer has different regulatory requirements. Our services are therefore tailored to the product characteristics, available documentation and project objectives.
Regulatory Assessment
We assess the pharmaceutical product, manufacturer and available documentation to identify applicable regulatory requirements.
This assessment provides a clear understanding of the project before a procedure begins and helps identify potential documentation or regulatory gaps.
This assessment provides a clear understanding of the project before a procedure begins and helps identify potential documentation or regulatory gaps.
Documentation Review
We review available technical and administrative information to identify missing documents, inconsistencies or information that must be completed before proceeding.
The initial review helps organize the documentation and establish a clear regulatory pathway for the project.
The initial review helps organize the documentation and establish a clear regulatory pathway for the project.
Pharmaceutical Regulatory Strategy
Together with the client, we define the most appropriate regulatory approach for the product.
The strategy considers the product characteristics, available information and requirements applicable in Peru, allowing the project to move forward in a structured and properly planned manner.
The strategy considers the product characteristics, available information and requirements applicable in Peru, allowing the project to move forward in a structured and properly planned manner.
Dossier Preparation & Submission
We support preparation and organization of the documentation required for the applicable procedure before the Peruvian health authority.
Our objective is to facilitate dossier management and ensure the required information is properly organized before submission.
Our objective is to facilitate dossier management and ensure the required information is properly organized before submission.
Local Representation & Regulatory Support
International manufacturers entering the Peruvian market may require a local structure to carry out certain regulatory activities.
IzzoMed provides local representation and regulatory support in Peru for international companies seeking to develop pharmaceutical projects in the country.
IzzoMed provides local representation and regulatory support in Peru for international companies seeking to develop pharmaceutical projects in the country.
Regulatory Procedure Follow-up
We support the project throughout the different stages of the regulatory procedure, monitoring progress and coordinating any actions required when additional information or documentation is requested.
Our work is designed to maintain clear communication throughout the project.
Our work is designed to maintain clear communication throughout the project.
Pharmaceutical Regulatory Affairs & Registration for International Manufacturers
Pharmaceutical registration in Peru requires a product-specific assessment of the applicable regulatory pathway and the dossier available from the manufacturer. Before filing, companies should review product composition, dosage form, manufacturing information, quality documentation, labeling and the evidence required for the relevant procedure.
Drug registration in Peru: dossier and submission planning
For an overview of the Peruvian regulatory authority, see our DIGEMID Peru guide. Manufacturers of other healthcare products can also review our medical device registration services in Peru.
For foreign manufacturers, drug registration in Peru should be planned before translations and document formalities are completed. A structured gap assessment can identify inconsistencies between certificates, product information and the proposed Peruvian dossier, reducing avoidable rework during the regulatory process.
DIGEMID states that applications for pharmaceutical sanitary registration are submitted electronically through VUCE for the applicable procedures and that access requires a valid sanitary authorization as a pharmaceutical establishment, such as a laboratory or droguería. The applicable requirements depend on the product and regulatory category.
Pharmaceutical registration in Peru: documents manufacturers should assess
Before preparing a drug registration in Peru, manufacturers should assess the product category and the documentation relevant to the applicable DIGEMID pathway. Depending on the product, this can include a Certificate of Pharmaceutical Product (CPP) or other accepted evidence of authorization, manufacturing and GMP documentation, qualitative and quantitative composition, specifications and analytical methods, stability information, proposed labeling and prescribing information. Requirements and document formalities must be confirmed for each application rather than assumed to be identical for all medicines.
IzzoMed can perform a pre-submission gap assessment and coordinate the local regulatory pathway. Manufacturers seeking a local regulatory structure can also review our Peru Registration Holder services or contact our regulatory team to discuss their product portfolio.
After pharmaceutical registration in Peru
Regulatory planning continues after approval. The registration holder should maintain the conditions under which the product was authorized and evaluate whether future changes require a regulatory modification or other action. Manufacturers should also coordinate registration maintenance with importation, storage, distribution and pharmacovigilance responsibilities.
International companies planning a broader launch can review our Healthcare Market Entry in Peru service, while our DIGEMID Peru guide provides an overview of the Peruvian regulatory authority.
For an international manufacturer, introducing a pharmaceutical product into Peru requires understanding local requirements and having an appropriate structure to manage regulatory activities.
At IzzoMed, we work with international manufacturers and pharmaceutical companies seeking to introduce pharmaceutical products into Peru.
Our support can begin at the earliest stages of a project, from product assessment and documentation review through regulatory procedure management and local representation.
Our approach helps manufacturers understand what is required to advance in the Peruvian market before committing resources to a regulatory procedure.
At IzzoMed, we work with international manufacturers and pharmaceutical companies seeking to introduce pharmaceutical products into Peru.
Our support can begin at the earliest stages of a project, from product assessment and documentation review through regulatory procedure management and local representation.
Our approach helps manufacturers understand what is required to advance in the Peruvian market before committing resources to a regulatory procedure.
Our Approach to Pharmaceutical Projects
Each project has different characteristics. Before defining the scope of services, we assess the product, manufacturer and available documentation.
1. Assess
We assess the pharmaceutical product, its manufacturer and available information to understand the project requirements.
2. Identify
We determine the applicable regulatory requirements and the product’s key documentation needs.
3. Plan
We define the regulatory strategy and steps required to advance the project.
4. Manage
We support preparation and management of the applicable procedure before the Peruvian health authority.
5. Support
We provide support throughout the procedure and, when applicable, after registration is obtained.
What Documentation Is Required to Register a Pharmaceutical Product in Peru?
Required documentation depends on the pharmaceutical product, manufacturer and applicable regulatory procedure.
We therefore recommend an initial regulatory assessment before starting the process.
Documentation that may be required when assessing a project can include:
We therefore recommend an initial regulatory assessment before starting the process.
Documentation that may be required when assessing a project can include:
Documentation must be assessed individually to determine the requirements applicable to each pharmaceutical product.
For manufacturers researching drug registration in Peru or DIGEMID pharmaceutical registration, IzzoMed reviews the product documentation, applicable registration pathway and local representation needs before dossier preparation. See our DIGEMID Peru guide, registration holder services and global partnerships.
Pharmaceutical Registration in Peru: CPP, GMP and Technical Dossier
For pharmaceutical registration in Peru, international manufacturers should evaluate the Certificate of Pharmaceutical Product (CPP) or Free Sale Certificate (FSC), applicable Good Manufacturing Practice (GMP) documentation, and the technical dossier required by the relevant DIGEMID pathway. Document acceptance, legal formalities and manufacturing-site requirements must be reviewed for each product.
Quality, Manufacturing and Stability Documentation
A dossier review may cover qualitative and quantitative composition, active pharmaceutical ingredient and excipient specifications, analytical methods, finished-product specifications, batch numbering, container-closure information, stability studies, labeling and product information. The precise evidence depends on the medicine and applicable regulatory category.
Variations, Renewals and Ongoing Compliance
After registration, changes to manufacturing, specifications, packaging or product information may require a regulatory variation or other action. Renewal and ongoing compliance planning should be assessed before the applicable deadlines. IzzoMed supports pharmaceutical regulatory affairs in Peru, including documentation review and project-specific coordination with the local registration holder.
For related services, see Regulatory Affairs in Peru and Peru Registration Holder. Official requirements should be checked with DIGEMID.
Why Conduct a Regulatory Assessment Before Registration?
Starting a procedure without first understanding the product’s regulatory requirements can lead to delays, requests for additional information or documentation gaps.
An initial regulatory assessment helps to:
An initial regulatory assessment helps to:
At IzzoMed, we believe effective regulatory planning begins before submitting the dossier.
Pharmaceutical Regulatory Affairs and Market Entry in Peru
Regulatory registration is an important part of pharmaceutical market entry, but a pharmaceutical project may involve additional operational and commercial requirements.
Our regulatory work can therefore be complemented with importation and storage coordination and identification and evaluation of potential distributors, according to each project’s requirements. Commercial distribution agreements are separate from IzzoMed’s regulatory representation services.
This approach allows our clients to assess regulatory and operational requirements as part of an integrated market-entry strategy.
Our regulatory work can therefore be complemented with importation and storage coordination and identification and evaluation of potential distributors, according to each project’s requirements. Commercial distribution agreements are separate from IzzoMed’s regulatory representation services.
This approach allows our clients to assess regulatory and operational requirements as part of an integrated market-entry strategy.
Do You Work with International Manufacturers?
We work with international manufacturers and pharmaceutical companies seeking to introduce their products into the Peruvian market.
Our support may include initial regulatory assessment, documentation review, regulatory strategy, procedure management and local representation, depending on each project’s requirements.
Our support may include initial regulatory assessment, documentation review, regulatory strategy, procedure management and local representation, depending on each project’s requirements.
Local Registration Holder and Pharmaceutical Market Entry Support in Peru
International pharmaceutical manufacturers entering Peru need a clear regulatory strategy for DIGEMID registration, dossier preparation and ongoing local responsibilities. IzzoMed supports the regulatory process and can provide local registration holder services under the applicable Peruvian requirements.
Our regulatory representation is separate from commercial distribution arrangements. We also assist manufacturers in identifying and evaluating potential local distributors without requiring exclusive distribution rights, helping them retain flexibility over their market-entry strategy.
Explore our Peru registration holder services and healthcare market entry support.
Planning to Register a Pharmaceutical Product in Peru?
If you are a pharmaceutical manufacturer or company seeking to introduce a pharmaceutical product into the Peruvian market, we can assess your project and identify the regulatory requirements and local services it may need.
Tell us about your product, manufacturer and project. We will assess the available information and define the next steps.
Tell us about your product, manufacturer and project. We will assess the available information and define the next steps.
For a pharmaceutical registration assessment, please provide the active ingredient, dosage form, strength, manufacturer country, and available GMP and CPP documentation. IzzoMed can review the initial DIGEMID pathway and propose the appropriate scope of regulatory support.